VEGF110

VEGF110 Overview

English NameVascular endothelial growth factor AApproved Drugs50
Drugs in Clinical Trials60Target SynonymVascular Endothelial Growth Factor,VEGF-A,MVCD1,Vascular endothelial growth factor A,VEGF,VEGFA,VPF,Vascular Endothelial Growth Factor A165,Vascular permeability factor,Vascular Endothelial Growth Factor A121
Highest Development StageApproved
English NameVascular endothelial growth factor A
Target SynonymVascular Endothelial Growth Factor,VEGF-A,MVCD1,Vascular endothelial growth factor A,VEGF,VEGFA,VPF,Vascular Endothelial Growth Factor A165,Vascular permeability factor,Vascular Endothelial Growth Factor A121
Approved Drugs50
Drugs in Clinical Trials60
Highest Development StageApproved

VEGF110 Product List

  • Product Category

    Protein (2)

  • Product Status

    Launched (2)

  • Species

    Human (2)

  • Tag

    Tag Free (1)His Tag (1)

  • Conjugate

    Unconjugated (2)

Total: 2
  • 1

VEGF110 Background

Vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF) and VEGF-A, and is a member of the platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) family and encodes a protein that is often found as a disulfide linked homodimer. This protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Alternatively spliced transcript variants, encoding either freely secreted or cell-associated isoforms, have been characterized. Alternatively spliced isoforms of 110,121,145,165,183,189 and 206 amino acids in length are expressed in humans.

VEGF110 Synonyms

RP1-261G23.1,MGC70609,MVCD1,VEGFA,VPF
  • Overview
  • Product List